ARCH Venture Partners X, LLC
SEC insider (Form 3/4/5 filer). CIK 0001769012. 10% Owner at Neumora Therapeutics, Inc. (NMRA) and 2 other issuers. 2 reported Form 4/5 transactions since Sep 2024; latest on Oct 27, 2025. Located in CHICAGO, IL.
Companies ARCH Venture Partners X, LLC has filed insider reports for
- Neumora Therapeutics, Inc. (NMRA): 10% Owner
- Prime Medicine, Inc. (PRME): 10% Owner
- Maze Therapeutics, Inc. (MAZE): 10% Owner
ARCH Venture Partners X, LLC
CIK: 0001769012
Transaction Breakdown
Open Market Buys (P)2 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
